Welcome to LookChem.com Sign In|Join Free
  • or
1-Piperidinecarboxylic acid, 4-[[[4-(4-amino-2-fluorophenoxy)-6-methoxy-7-quinolinyl]oxy]methyl]-, 1,1-dimethylethyl ester, commonly known as trelagliptin, is a complex organic compound that functions as a dipeptidyl peptidase-4 (DPP-4) inhibitor. It is utilized in the medical field for the treatment of type 2 diabetes, where it plays a crucial role in regulating blood sugar levels.
Used in Pharmaceutical Industry:
Trelagliptin is used as an antidiabetic medication for the treatment of type 2 diabetes. It operates by inhibiting the DPP-4 enzyme, which is responsible for breaking down incretin hormones. This inhibition leads to an increase in the levels of incretin hormones, stimulating the release of insulin and reducing glucose production in the liver, ultimately resulting in improved blood sugar control for patients with type 2 diabetes.

929252-65-3

Post Buying Request

929252-65-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

929252-65-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 929252-65-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,9,2,5 and 2 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 929252-65:
(8*9)+(7*2)+(6*9)+(5*2)+(4*5)+(3*2)+(2*6)+(1*5)=193
193 % 10 = 3
So 929252-65-3 is a valid CAS Registry Number.

929252-65-3Relevant academic research and scientific papers

Preparation method of aryloxy quinoline compound

-

, (2021/04/29)

The invention provides a preparation method of an aryloxy quinoline compound, and particularly provides a method for preparing an aryloxy quinoline compound with a structure shown in a formula (I) by taking 4-chloro-6-methoxy-7-quinolinol as a starting ra

PHARMACEUTICALLY ACTIVE COMPOUNDS AS AXL INHIBITORS

-

Page/Page column 105, (2012/03/26)

The present invention relates to 1-nitrogen-heterocyclic-2-carboxamides of general formula (I): and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the treatment and/or prevention of Axl receptor tyrosine kinase subfamily induced disorders, including cancer and primary tumor metastases, and pharmaceutical compositions containing at least one of said 1-nitrogen-heterocyclic-2-carboxamide derivatives and/or pharmaceutically acceptable salts thereof.

Pharmaceutically active compounds as Axl inhibitors

-

Paragraph 0140, (2013/03/26)

The present invention relates to 1-nitrogen-heterocyclic-2-carboxamides of general formula (I): and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the treatment and/or prevention of Axl receptor tyrosine kinase subfamily induced disorders, including cancer and primary tumor metastases, and pharmaceutical compositions containing at least one of said 1-nitrogen-heterocyclic-2-carboxamide derivatives and/or pharmaceutically acceptable salts thereof.

Met kinase inhibitors

-

Page/Page column 17-18, (2010/11/26)

The present invention is directed to compounds that are useful for treating cancer having one of the following Formulas:

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 929252-65-3